Stevens Capital Management LP Charles River Laboratories International, Inc. Transaction History

Stevens Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$126.05 - $152.76 $417,981 - $506,552	-3,316 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$125.07 - $143.67 $414,732 - $476,409	3,316 New	3,316 $439,000
Q1 2019 May 03, 2019	SELL	$104.82 - $146.73 $567,285 - $794,102	-5,412 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$105.09 - $137.23 $568,747 - $742,688	5,412 New	5,412 $613,000
Q4 2017 Feb 13, 2018	SELL	$100.43 - $118.09 $3.67 Million - $4.32 Million	-36,563 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$96.72 - $109.26 $3.54 Million - $3.99 Million	36,563	36,563 $3.95 Million

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.48B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.